TCI Wealth Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$150 1302
2023
Q1
$150 Hold
100
﹤0.01% 2365
2022
Q4
$117 Hold
100
﹤0.01% 2393
2022
Q3
$0 Sell
100
-100
-50% -$147 ﹤0.01% 2443
2022
Q2
$0 Hold
200
﹤0.01% 2411
2022
Q1
$0 Sell
200
-1,937
-91% -$3K ﹤0.01% 2345
2021
Q4
$5K Buy
+2,137
New +$5K ﹤0.01% 1676
2019
Q1
Sell
-1,300
Closed -$1K 1480
2018
Q4
$1K Sell
1,300
-186
-13% -$285 ﹤0.01% 1250
2018
Q3
$3K Hold
1,486
﹤0.01% 931
2018
Q2
$3K Hold
1,486
﹤0.01% 951
2018
Q1
$3K Hold
1,486
﹤0.01% 860
2017
Q4
$3K Hold
1,486
﹤0.01% 915
2017
Q3
$4K Hold
1,486
﹤0.01% 783
2017
Q2
$4K Hold
1,486
﹤0.01% 812
2017
Q1
$4K Hold
1,486
﹤0.01% 769
2016
Q4
$5K Buy
+1,486
New +$4.56K ﹤0.01% 776

Other funds holding LCTX